Effect of ivabradine on the activity of retinal ganglion cells
-
1
University Medical Center Göttingen, Department of Ophthalmology, Germany
Ivabradine is a new bradycardic agent which was approved for symptomatic management of stable angina pectoris and acts by blocking of HCN4-channels in the sinoatrial node (1). About 15 % of patients treated with ivabradine report slight and completely reversible luminous phenomena (phosphenes), which occured after 2 month of medication (2).
Ivabradine is thought to induce phosphenes by blocking hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels in photoreceptors. These channels play an important role in shaping the membrane potential after activation and are therefore thought to be essential for efficient encoding of stimuli at high-frequency (3). Blocking HCN channels causes prolonged hyperpolarization of photoreceptor inner segments, and knock-out studies revealed the importance of retinal HCN-channels for mesopic cone vision (4).
Yet, experiments investigating the pharmacological induction of phosphenes by ivabradine have so far focused on histology, photoreceptor electrophysiology (5) or electroretinograms (6).
Complementary to these studies, we here focus on the effect of ivabradine on the encoding of visual signals at the output stage of the retina that is in the activity of retinal ganglion cells. In particular, we search for spike pattern in RGC activity after administration of ivabradine that could underlie the reported phosphenes.
To do so, we mounted isolated mouse retina on a 252-channel multielectrode array to record spikes from individual ganglion cells. We measured spontaneous activity as well as response to a series of light stimuli (steps in light intensity, different types of temporal and spatio-temporal flicker) before, during and after administration of 3 µM ivabradine.
Preliminary results show altered spontaneous activity in RGCs during ivabradine administration, with ON-type RGCs primarily showing increased and OFF-type RGCs rather decreased spontaneous activation.
We hypothesize that this imbalanced spontaneous activity by ON-type and OFF-type RGCs may contribute to luminous phenomena reported by patients treated with ivabradine.
This work was supported by the German Initiative of Excellence, the International Human Frontier Science Program Organization, and the Deutsche Forschungsgemeinschaft (DFG-SFB 889).
References
1. Postea O and Biel M. Exploring HCN channels as novel drug targets. Nat Rev Drug Discov, 10(12), 903-14 (2011).
2. Cervetto L et al. Cellular mechanisms underlying the pharmacological induction of phosphenes. Br J Pharmacol, 150(4), 383-90 (2007).
3. Barrow AJ and Wu SM. Low-conductance HCN1 ion channels augment the frequency response of rod and cone photoreceptors. J Neurosci, 29(18), 5841-53 (2009).
4. Seeliger MW et al. Modulation of rod photoreceptor output by HCN1 channels is essential for regular mesopic cone vision. Nat Commun, doi: 10.1038/ncomms1540, 2:532 (2011).
5. Demontis GC et al. Selective HCN1 channels inhibition by ivabradine in mouse photoreceptors. Invest Ophthalmol Vis Sci, 50(4), 1948-55 (2008).
6. Della Santina L et al. Effect of HCN channel inhibition on retinal morphology and function in normal and dystrophic rodents. Invest Ophthalmol Vis Sci, 51(2), 1016-23 (2009).
Keywords:
HCN channel,
ivabradine,
Retina,
retinal ganglion cell
Conference:
Bernstein Conference 2012, Munich, Germany, 12 Sep - 14 Sep, 2012.
Presentation Type:
Poster
Topic:
Sensory processing and perception
Citation:
Bemme
S,
Weick
M and
Gollisch
T
(2012). Effect of ivabradine on the activity of retinal ganglion cells.
Front. Comput. Neurosci.
Conference Abstract:
Bernstein Conference 2012.
doi: 10.3389/conf.fncom.2012.55.00148
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
11 May 2012;
Published Online:
12 Sep 2012.
*
Correspondence:
Mr. Sebastian Bemme, University Medical Center Göttingen, Department of Ophthalmology, Göttingen, Lower Saxony, 37075, Germany, Sebboem@gmx.de